New Therapeutics for Heart Failure: Focusing on cGMP Signaling

Current drugs for treating heart failure (HF), for example, angiotensin II receptor blockers and β-blockers, possess specific target molecules involved in the regulation of the cardiac circulatory system. However, most clinically approved drugs are effective in the treatment of HF with reduced eject...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangmool, Supachoke, Duangrat, Ratchanee, Parichatikanond, Warisara, Kurose, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454066/
https://www.ncbi.nlm.nih.gov/pubmed/37629047
http://dx.doi.org/10.3390/ijms241612866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454066/
https://www.ncbi.nlm.nih.gov/pubmed/37629047
http://dx.doi.org/10.3390/ijms241612866

Ejemplares similares